In this context, increasing evidence supports the contention that NLRP3 inflammasome activation and the consequent massive release of IL-1β and IL-18 following MSU deposition promote mast cell, monocyte, and neutrophil influx into the synovium and joint fluids, thus contributing to the pathophysiology of gout [116,117,118]. Here, NLRP3 is linked to gout.